ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
IMMUCELL CORP /DE/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.51−0.24 (-2.23%)
Close on Oct 19, 2026
- Market cap
- $96.58M
- P/E (TTM)
- 131.4
- Dividend yield
- –
SEC filings
40 of Immucell's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 12, 2026 | Oct 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2026 | Jul 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 10, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2026 | Apr 8, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 18, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2026 | Mar 4, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Feb 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 24, 2025 | Dec 29, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2025 | Oct 7, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2025 | Sep 30, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2025 | Aug 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2025 | Jul 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 17, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 24, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 8, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 4, 2025 | Apr 7, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 16, 2025 | Jan 16, 2025 | SEC EDGAR |